original articlesthoracic tumorsClinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer
thoracic tumors
Under an Elsevier user license
open archive
Key words
next-generation sequencing
lung cancer
driver mutation
transbronchial biopsy
targeted therapy
Cited by (0)
- †
Both authors contributed equally to this work.
Copyright © 2015 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.